世界の静脈注射用溶液市場2021-2028:種類別(TPN、PPN)、栄養素別(炭水化物、単回投与アミノ酸溶液、非経口脂質エマルジョン)、地域別

◆英語タイトル:Intravenous Solutions Market Size, Share & Trends Analysis Report By Type (TPN, PPN), By Nutrients (Carbohydrates, Single Dose Amino Acid Solution, Parenteral Lipid Emulsion), By Region, And Segment Forecasts, 2021 - 2028
◆商品コード:GV21MA005
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2021年2月26日
◆ページ数:114
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥678,300見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥792,300見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,020,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

グランドビューリサーチ社は、世界の静脈注射用溶液市場規模が2028年までに189億ドルに達すると予測しています。2021年から2028年までに年平均7.9%成長する見通しです。本調査レポートでは、静脈注射用溶液の世界市場について広く調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、競争分析、種類別(中心静脈栄養法(TPN) 、末梢静脈栄養法(PPN))分析、栄養素別(炭水化物、単回投与アミノ酸溶液、ビタミン・ミネラル(塩・電解質)、非経口脂質エマルジョン、その他)分析、地域別分析、競争状況など、以下の構成でまとめております。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・競争分析
・静脈注射用溶液の世界市場規模:種類別(中心静脈栄養法(TPN) 、末梢静脈栄養法(PPN))
・静脈注射用溶液の世界市場規模:栄養素別(炭水化物、単回投与アミノ酸溶液、ビタミン・ミネラル(塩・電解質)、非経口脂質エマルジョン、その他)
・静脈注射用溶液の世界市場規模:地域別
・競争状況
【レポートの概要】

IV Solutions Market Growth & Trends

The global intravenous solutions market size is expected to reach USD 18.9 billion by 2028 according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.9% from 2021 to 2028. The growing incidence rate of chronic diseases such as cancer, increase in the number of premature births, and shortage of I.V. solutions in the U.S. are some of the key factors expected to drive the market.

One of the prime areas wherein intravenous (IV) fluids find usage is severe dehydration. Severe dehydration is seen in diseases such as diarrhea, resulting in the depletion of fluids from the body. According to the WHO, in 2017, diarrhea was the second leading cause of death in children under 5 years of age with around 5,25,000 lives lost each year. Intravenous (IV) fluids can play a key role in the treatment and prevention of deaths caused due to the dehydration/fluid loss associated with diarrhea. Other cases where intravenous fluids find application include surgeries and emergency situations.

The ongoing COVID-19 pandemic is expected to have a positive impact on the market. Intensive Care Units (ICU) worldwide are either operating at full capacity or are overcrowded due to the high influx of patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As per an article published by BBC, in January 2021, critical care wards across England were running in full capacity. Nutritional care is one of the essential elements in managing these patients. This has increased the demand for intravenous (IV) fluids, as many of the patients, especially the elderly population are placed on ventilators and are unable to consume food orally.

IV Solutions Market Report Highlights

• The Total Parenteral Nutrition (TPN) segment led the segment in terms of revenue share in 2020 owing to its growing applications in the management of chronic diseases

• The increasing number of surgeries and post-operative nutritional management is a prime factor driving the vitamins and minerals (salt and electrolyte) segment’s growth

• North America dominated the market with a revenue share of nearly 40.8% in 2020 due to the high usage of IV fluids in the U.S.

【レポートの目次】

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Nutrients
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1:
1.9.2. Objective 2:
1.9.3. Objective 3:
1.9.4. Objective 4:
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Intravenous (IV) Solutions Market Variables, Trends & Scope
3.1. Penetration & Growth Prospect Mapping
3.2. Industry Value Chain Analysis
3.2.1. Reimbursement framework
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.3.3. Industry challenges
3.4. Intravenous (IV) solutions Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
3.4.3. Major Deals & Strategic Alliances Analysis
3.4.4. Market Entry Strategies
Chapter 4. Intravenous (IV) Solutions Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Definitions and Scope
4.3. Intravenous (IV) solutions Market Share, 2020 & 2028
4.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
4.4.1. Total Parenteral Nutrition (TPN)
4.4.2. Peripheral Parenteral Nutrition (PPN)
Chapter 5. Intravenous (IV) Solutions Market: Nutrients Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Definitions and Scope
5.3. Intravenous (IV) solutions Market Share, 2020 & 2028
5.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
5.4.1. Carbohydrates
5.4.2. Single Dose Amino Acid Solution
5.4.3. Vitamins & Minerals (Salt and electrolyte)
5.4.4. Parenteral Lipid Emulsion
5.4.5. Others
Chapter 6. Intravenous (IV) Solutions Market: Regional Estimates & Trend Analysis
6.1. Regional Market Dashboard
6.2. Regional Market Share Analysis, 2020 & 2028
6.3. Regional Market Share, 2020
6.4. North America
6.4.1. Market estimates and forecast, 2016 – 2028 (USD Million)
6.4.2. U.S.
6.4.2.1. Market estimates and forecast, 2016 – 2028 (USD Million)
6.4.3. Canada
6.4.3.1. Market estimates and forecast, 2016 – 2028 (USD Million)
6.5. Europe
6.5.1. Market estimates and forecast, 2016 – 2028 (USD Million)
6.5.2. U.K.
6.5.2.1. Market estimates and forecast, 2016 – 2028 (USD Million)
6.5.3. Germany
6.5.3.1. Market estimates and forecast, 2016 – 2028 (USD Million)
6.5.4. France
6.5.4.1. Market estimates and forecast, 2016 – 2028 (USD Million)
6.5.5. Russia
6.5.5.1. Market estimates and forecast, 2016 – 2028 (USD Million)
6.5.6. Switzerland
6.5.6.1. Market estimates and forecast, 2016 – 2028 (USD Million)
6.6. Asia Pacific
6.6.1. Market estimates and forecast, 2016 – 2028 (USD Million)
6.6.2. Japan
6.6.2.1. Market estimates and forecast, 2016 – 2028 (USD Million)
6.6.3. China
6.6.3.1. Market estimates and forecast, 2016 – 2028 (USD Million)
6.6.4. India
6.6.4.1. Market estimates and forecast, 2016 – 2028 (USD Million)
6.6.5. Australia
6.6.5.1. Market estimates and forecast, 2016 – 2028 (USD Million)
6.6.6. South Korea
6.6.6.1. Market estimates and forecast, 2016 – 2028 (USD Million)
6.7. Latin America
6.7.1. Market estimates and forecast, 2016 – 2028 (USD Million)
6.7.2. Brazil
6.7.2.1. Market estimates and forecast, 2016 – 2028 (USD Million)
6.7.3. Mexico
6.7.3.1. Market estimates and forecast, 2016 – 2028 (USD Million)
6.8. MEA
6.8.1. Market estimates and forecast, 2016 – 2028 (USD Million)
6.8.2. South Africa
6.8.2.1. Market estimates and forecast, 2016 – 2028 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.1.1. Fresenius Kabi
7.1.1.1. Company overview
7.1.1.2. Financial performance
7.1.1.3. Product benchmarking
7.1.1.4. Strategic initiatives
7.1.2. Sino-Swed Pharmaceutical Corp., Ltd.
7.1.2.1. Company overview
7.1.2.2. Financial performance
7.1.2.3. Product benchmarking
7.1.2.4. Strategic initiatives
7.1.3. Hospira
7.1.3.1. Company overview
7.1.3.2. Financial performance
7.1.3.3. Product benchmarking
7.1.3.4. Strategic initiatives
7.1.4. Amanta Healthcare.
7.1.4.1. Company overview
7.1.4.2. Financial performance
7.1.4.3. Product benchmarking
7.1.4.4. Strategic initiatives
7.1.5. Otsuka Pharmaceutical Co., Ltd.
7.1.5.1. Company overview
7.1.5.2. Financial performance
7.1.5.3. Product benchmarking
7.1.5.4. Strategic initiatives
7.1.6. Sichuan Kelun Pharmaceutical Co., Ltd.
7.1.6.1. Company overview
7.1.6.2. Financial performance
7.1.6.3. Product benchmarking
7.1.6.4. Strategic initiatives
7.1.7. Terumo Corporation
7.1.7.1. Company overview
7.1.7.2. Financial performance
7.1.7.3. Product benchmarking
7.1.7.4. Strategic initiatives
7.1.8. Baxter
7.1.8.1. Company overview
7.1.8.2. Financial performance
7.1.8.3. Product benchmarking
7.1.8.4. Strategic initiatives
7.1.9. B. Braun Melsungen AG
7.1.9.1. Company overview
7.1.9.2. Financial performance
7.1.9.3. Product benchmarking
7.1.9.4. Strategic initiatives
7.1.10. Claris Lifesciences Ltd.
7.1.10.1. Company overview
7.1.10.2. Financial performance
7.1.10.3. Product benchmarking
7.1.10.4. Strategic initiatives
7.1.11. Kyowa Hakko Bio Co., Ltd.
7.1.11.1. Company overview
7.1.11.2. Financial performance
7.1.11.3. Product benchmarking
7.1.11.4. Strategic initiatives
7.1.12. Grifols
7.1.12.1. Company overview
7.1.12.2. Financial performance
7.1.12.3. Product benchmarking
7.1.12.4. Strategic initiatives
7.1.13. Liqvor Pharmaceuticals
7.1.13.1. Company overview
7.1.13.2. Financial performance
7.1.13.3. Product benchmarking
7.1.13.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 List of Secondary Sources
Table 3 Global Intravenous (IV) Solutions Market, by Region 2016 - 2028 (USD Million)
Table 4 Global Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 5 Global Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 6 North America Intravenous (IV) Solutions Market, by Country, 2016 - 2028 (USD Million)
Table 7 North America Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 8 North America Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 9 U.S. Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 10 U.S. Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 11 Canada Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 12 Canada Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 13 Europe Intravenous (IV) Solutions Market, by Country, 2016 - 2028 (USD Million)
Table 14 Europe Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 15 Europe Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 16 U.K. Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 17 U.K. Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 18 Germany Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 19 Germany Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 20 France Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 21 France Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 22 Russia Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 23 Russia Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 24 Switzerland Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 25 Switzerland Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 26 Asia Pacific Intravenous (IV) Solutions Market, by Country, 2016 - 2028 (USD Million)
Table 27 Asia Pacific Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 28 Asia Pacific Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 29 Japan Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 30 Japan Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 31 China Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 32 China Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 33 India Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 34 India Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 35 Australia Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 36 Australia Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 37 South Korea Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 38 South Korea Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 39 Latin America Intravenous (IV) Solutions Market, by Country, 2016 - 2028 (USD Million)
Table 40 Latin America Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 41 Latin America Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 42 Brazil Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 43 Brazil Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 44 Mexico Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 45 Mexico Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 46 MEA Intravenous (IV) Solutions Market, by Country, 2016 - 2028 (USD Million)
Table 47 MEA Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 48 MEA Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 49 South Africa Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million))
Table 50 South Africa Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value - chain - based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Intravenous (IV) Solutions market :Market snapshot
Fig. 9 Intravenous (IV) Solutions market :Market segmentation
Fig. 10 Intravenous (IV) Solutions market Strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Intravenous (IV) Solutions market driver impact
Fig. 14 Intravenous (IV) Solutions market restraint impact
Fig. 15 Intravenous (IV) Solutions market porter’s five forces analysis
Fig. 16 Intravenous (IV) Solutions market PESTEL analysis
Fig. 17 Intravenous (IV) Solutions market segment dashboard
Fig. 18 Intravenous (IV) Solutions market: Type movement Analysis
Fig. 19 Total Parenteral Nutrition (TPN) market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 20 Peripheral Parenteral Nutrition (PPN) market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 21 Intravenous (IV) Solutions market segment dashboard
Fig. 22 Intravenous (IV) Solutions market: Nutrients movement Analysis
Fig. 23 Carbohydrates market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 24 Single Dose Amino Acid Solution market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 25 Vitamins & Minerals (Salt and electrolyte) market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 26 Other nutrients market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 27 Parenteral Lipid Emulsion market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 28 Global Intravenous (IV) Solutions market: Regional movement analysis
Fig. 29 Global market share, by region
Fig. 30 North America market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 31 U.S. market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 32 Canada market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 33 Europe market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 34 U.K. market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 35 Germany market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 36 France market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 37 Russia market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 38 Switzerland market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 39 Asia Pacific market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 40 Japan market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 41 China market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 42 India market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 43 Australia market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 44 South Korea market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 45 Latin America market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 46 Brazil market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 47 Mexico market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 48 Middle East and Africa market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 49 South Africa market estimates and forecast, 2016 - 2028 (USD Million)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の静脈注射用溶液市場2021-2028:種類別(TPN、PPN)、栄養素別(炭水化物、単回投与アミノ酸溶液、非経口脂質エマルジョン)、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆